Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Comment by Rarbar99on Sep 30, 2021 10:10am
80 Views
Post# 33943063

RE:RE:RE:Funny to see

RE:RE:RE:Funny to see

I showed you my car that costs 10x more than my shares, was that not enough for you? 

And I don't care how many shares you own or what your average price is. I solely care about your lies. You specifically told me that you are still making a profit and bought your shares at the 2017 price levels. Yet I exposed you and showed proof that you only started investing here in February 2020. There is absolutely no way you are making money here, and that's why you can't show us your portfolio. Next time don't lie and you won't have to get caught in the corner. You pathetic little rat.


Inthepez wrote: That’s your job. To lie about the company and pretend you even own shares.

I challenge you to post your shares and
your average price lmao. 

Rarbar99 wrote:

 

Inthepez wrote: Yukon “spam the board” Jizza is thinking about me at 3:30am lmao. 

 

 

say what you want about Yukon, but at least he doesn't have to lie about his average price.  


To be bullish on this company is one thing, but now miserable do you have to be to lie about how much money you've lost? 





<< Previous
Bullboard Posts
Next >>